Use of <em>SRC</em> pathway activation in predicting dasatinib activity in ovarian cancer

Wallace, Amy

289 - Poster Session A
Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer

Saturday, March 22, 2014: 11:45 AM

West Exhibit Hall (Tampa Convention Center)

A. Wallace¹, D. Corcoran², M. Lopez¹, D. G. K. Teoh³, D. Adams¹, L. Grace¹ and A. A. Secord¹
¹Duke University Medical Center, Durham, NC, ²Duke Institute for Genome Sciences and Policy, Durham, NC, ³University of Minnesota, Minneapolis, MN

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

289 - Poster Session A
Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer

289 - Poster Session A Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer

289 - Poster Session A
Use of SRC pathway activation in predicting dasatinib activity in ovarian cancer